German eHealth specialist enters CanadaInterComponentWare launches in Toronto Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). Prescription recycling back in the limelight CMA leader-to-be admits to redistributing unused meds ORTHOPEDICS: That shoe may not fit ORTHOPEDICS: Canadians debunk hip resurfacing hype Meeting also highlights growing concern over adverse reactions to metal-on-metal implants LETTERS: B.C. college defends real-world walk-in policy DIGESTIVE DISEASES: Endoscopy review finds long waits for patients with serious symptoms Ensuring treatment for all in a time of war First Previous 2321 2322 2323 2324 2325 Next Last
